Luis Carreño

3.2k total citations
69 papers, 2.2k citations indexed

About

Luis Carreño is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Luis Carreño has authored 69 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Rheumatology, 17 papers in Immunology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Luis Carreño's work include Rheumatoid Arthritis Research and Therapies (30 papers), Systemic Lupus Erythematosus Research (28 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). Luis Carreño is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (30 papers), Systemic Lupus Erythematosus Research (28 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). Luis Carreño collaborates with scholars based in Spain, United States and United Kingdom. Luis Carreño's co-authors include I. Monteagudo, Manuel Figueroa, Vicente Rodríguez‐Valverde, Carlos González, Juan J. Gómez‐Reino, Francisco Javier López‐Longo, Loreto Carmona, Dolores Montero, Emilio Martín Mola and Eliseo Pascual and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Bone and Mineral Research and Annals of the Rheumatic Diseases.

In The Last Decade

Luis Carreño

68 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luis Carreño Spain	20	1.4k	574	419	358	353	69	2.2k
Xavier Mariette France	13	671 0.5×	554 1.0×	286 0.7×	284 0.8×	310 0.9×	40	1.7k
Jean‐Charles Piette France	19	2.5k 1.8×	775 1.4×	426 1.0×	161 0.4×	1.0k 2.9×	19	3.7k
Murat İnanç Türkiye	28	1.6k 1.1×	746 1.3×	328 0.8×	113 0.3×	463 1.3×	134	2.9k
Karim Sacré France	26	881 0.6×	620 1.1×	237 0.6×	135 0.4×	156 0.4×	116	2.1k
R. John Looney United States	18	1.0k 0.8×	1.3k 2.3×	198 0.5×	444 1.2×	248 0.7×	25	2.5k
Alberto Berman Argentina	20	1.3k 0.9×	737 1.3×	157 0.4×	260 0.7×	683 1.9×	39	2.0k
C. Larroche France	26	577 0.4×	758 1.3×	316 0.8×	284 0.8×	686 1.9×	68	2.3k
Masaya Mukai Japan	20	554 0.4×	272 0.5×	548 1.3×	146 0.4×	287 0.8×	202	2.0k
Wendell A. Wilson United States	17	2.0k 1.4×	505 0.9×	286 0.7×	230 0.6×	1.1k 3.1×	26	2.5k
David M. Menke United States	24	556 0.4×	254 0.4×	442 1.1×	309 0.9×	224 0.6×	93	2.2k

Countries citing papers authored by Luis Carreño

Since Specialization

Citations

This map shows the geographic impact of Luis Carreño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Carreño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Carreño more than expected).

Fields of papers citing papers by Luis Carreño

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Carreño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Carreño. The network helps show where Luis Carreño may publish in the future.

Co-authorship network of co-authors of Luis Carreño

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Carreño. A scholar is included among the top collaborators of Luis Carreño based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Carreño. Luis Carreño is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Álvaro‐Gracia, José María, Juan Ángel Jover, Rosario García‐Vicuña, et al.. (2016). Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Annals of the Rheumatic Diseases. 76(1). 196–202. 202 indexed citations

Janta, I., Esperanza Naredo, Juan Carlos Nieto‐González, et al.. (2016). How does a cadaver model work for testing ultrasound diagnostic capability for rheumatic-like tendon damage?. Rheumatology International. 36(6). 863–869. 1 indexed citations

Damjanov, Nemanja, Vera Milić, Juan Carlos Nieto‐González, et al.. (2016). Multiobserver Reliability of Ultrasound Assessment of Salivary Glands in Patients with Established Primary Sjögren Syndrome. The Journal of Rheumatology. 43(10). 1858–1863. 18 indexed citations

Nieto‐González, Juan Carlos, et al.. (2015). Impact of musculoskeletal ultrasound on clinical practice in paediatric rheumatology.. PubMed. 33(4). 583–7. 4 indexed citations

Janta, I., Lara Valor, Inmaculada de la Torre, et al.. (2015). Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?. Rheumatology International. 36(3). 387–396. 12 indexed citations

Naredo, Esperanza, Lara Valor, Inmaculada de la Torre, et al.. (2015). Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis. Lara D. Veeken. 54(8). 1408–1414. 89 indexed citations

Janta, I., Lina Martínez‐Estupiñán, Lara Valor, et al.. (2015). Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment. Clinical Rheumatology. 34(5). 935–942. 15 indexed citations

Álvaro‐Gracia, José María, Rosario García‐Vicuña, Luis Carreño, et al.. (2013). Phase IB/Iia Study On Intravenous Administration Of Expanded Allogeneic Adipose-Derived Mesenchymal Stem Cells In Refractory Rheumatoid Arthritis Patients. Arthritis & Rheumatism. 65. 6 indexed citations

Valor, Lara, I. Monteagudo, Inmaculada de la Torre, et al.. (2013). Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept. Modern Rheumatology. 1 indexed citations

10.

Rubbert‐Roth, Andrea, P. P. Tak, Cristiano A. F. Zerbini, et al.. (2010). Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR). Lara D. Veeken. 49(9). 1683–1693. 139 indexed citations

11.

López‐Longo, Francisco Javier, Silvia Sánchez‐Ramón, & Luis Carreño. (2009). The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: Do they imply new risk factors?. Drug News & Perspectives. 22(9). 543–543. 23 indexed citations

12.

López‐Longo, Francisco Javier, Inmaculada de la Torre, Silvia Sánchez‐Ramón, et al.. (2009). Association between anti–cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Care & Research. 61(4). 419–424. 136 indexed citations

13.

Olazarán, Javier, et al.. (2009). Cognitive Dysfunction in Systemic Lupus Erythematosus: Prevalence and Correlates. European Neurology. 62(1). 49–55. 28 indexed citations

14.

Dieguez‐Gonzalez, Rebeca, Manuel Calaza, Eva Pérez‐Pampín, et al.. (2009). Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. Arthritis Research & Therapy. 11(2). R42–R42. 50 indexed citations

15.

Carbone, Javier, et al.. (2007). Combined Therapy with Rituximab Plus Cyclophosphamide/Vincristine/Prednisone for Sjogren’s Syndrome-Associated B-Cell Non-Hodgkin’s Lymphoma. Clinical Reviews in Allergy & Immunology. 34(1). 80–84. 7 indexed citations

16.

López‐Longo, Francisco Javier, Silvia Sánchez‐Ramón, Beatriz Santamaría, et al.. (2005). Prevalence of IgG Anti‐α‐Fodrin Antibodies in Sjögren's Syndrome. Annals of the New York Academy of Sciences. 1050(1). 210–216. 12 indexed citations

17.

Carreño, Luis, et al.. (2002). Experiencia con infliximab en el tratamiento de pacientes con artritis reumatoide refractaria en el Hospital Gregorio Marañón (HGUGM) frente a los resultados del estudio ATTRACT. 29(3). 112–115. 1 indexed citations

18.

González, Carlos, Francisco Javier López‐Longo, Johanne Samson, et al.. (1998). Antiribonucleoprotein Antibodies in Children with HIV Infection: A Comparative Study with Childhood-Onset Systemic Lupus Erythematosus. AIDS Patient Care and STDs. 12(1). 21–28. 11 indexed citations

19.

Rodríguez‐Mahou, Margarita, J. Lόpez-Longo, Normand Lapointe, et al.. (1994). Autoimmune phenomena in children with Human Immunodeficiency Virus infection and Acquired Immunodeficiency Syndrome. Acta Paediatrica. 83(s400). 31–34. 12 indexed citations

20.

Zapatero, J., et al.. (1988). Costal chondritis in heroin addicts: a comparative study with postsurgical chondritis. British Journal of Diseases of the Chest. 82(4). 341–346. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact